Literature DB >> 7055742

Hypermagnesaemia and anaesthetic management.

M N Skaredoff, E R Roaf, S Datta.   

Abstract

The anaesthetic management of a pre-eclamptic parturient who was treated with high doses of magnesium sulphate and who developed hypermagnesaemia before delivery by Caesarean Section, is presented. The pharmacology of magnesium, particularly its effects at the neuromuscular junction, and clinical considerations of magnesium administration are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7055742     DOI: 10.1007/bf03007946

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  44 in total

1.  Plasma levels of magnesium attained in magnesium sulfate therapy for preeclampsia and eclampsia.

Authors:  L C CHESLEY; I TEPPER
Journal:  Surg Clin North Am       Date:  1957-04       Impact factor: 2.741

2.  The action of magnesium on the heart.

Authors:  P SZEKELY
Journal:  Br Heart J       Date:  1946-07

3.  Existence and role of a slow inward current during the frog atrial action potential.

Authors:  O Rougier; G Vassort; D Garnier; Y M Gargouil; E Coraboeuf
Journal:  Pflugers Arch       Date:  1969       Impact factor: 3.657

4.  Does magnesium produce anesthesia? Evaluation of its effects on the cardiovascular and neurologic systems.

Authors:  J A Aldrete; D R Barnes; J K Aikawa
Journal:  Anesth Analg       Date:  1968 Jul-Aug       Impact factor: 5.108

5.  Magnesium and seizure control.

Authors:  W C Shelley; B B Gutsche
Journal:  Am J Obstet Gynecol       Date:  1980-01-01       Impact factor: 8.661

6.  Small systems of neurons.

Authors:  E R Kandel
Journal:  Sci Am       Date:  1979-09       Impact factor: 2.142

7.  [Electrophysiological analysis of myocard membrane properties during the plateau of the action potential, existence of a slow inward current in solutions without divalent ions].

Authors:  D Garnier; O Rougier; Y M Gargouïl; E Coraboeuf
Journal:  Pflugers Arch       Date:  1969       Impact factor: 3.657

8.  Failure to anesthetize human subjects by intravenous administration of magnesium sulfate.

Authors:  G Somjen; M Hilmy; C R Stephen
Journal:  J Pharmacol Exp Ther       Date:  1966-12       Impact factor: 4.030

9.  The management of severe pre-eclampsia and eclampsia.

Authors:  B M Hibbard; M Rosen
Journal:  Br J Anaesth       Date:  1977-01       Impact factor: 9.166

10.  Hypocalcemia after therapeutic use of magnesium sulfate.

Authors:  E Eisenbud; C C LoBue
Journal:  Arch Intern Med       Date:  1976-06
View more
  1 in total

1.  [The use of magnesium sulfate during surgery of pheochromocytoma: apropos of 2 cases].

Authors:  P Drolet; M Girard
Journal:  Can J Anaesth       Date:  1993-06       Impact factor: 5.063

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.